We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants

Delisted

COEPW was delisted on the 24th of April, 2026.

13 hedge funds and large institutions have $25.1K invested in Coeptis Therapeutics Warrants in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more capital invested

Capital invested by funds: $9.72K → $25.1K (+$15.4K)

24.96% more ownership

Funds ownership: 2.06%27.02% (+25%)

0% more funds holding

Funds holding: 1313 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

COEPW Hedge Fund Activity: Q2 2025 in Review

13 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2025, worth a combined $25.1K — up 158% from $9.72K a quarter earlier.

Fund positioning in COEPW was balanced in Q2 2025: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.2K. The largest seller was Osaic Holdings, exiting entirely with an estimated $189 sold.

  • 13 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $25.1K of Coeptis Therapeutics Warrants stock for Q2 2025, up 158% quarter-over-quarter.
  • 3 funds opened new Coeptis Therapeutics Warrants positions in Q2 2025 and 3 closed out, a net change of 0 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q2 2025 was Susquehanna International Group, an estimated $1.2K added.
  • The largest Coeptis Therapeutics Warrants seller in Q2 2025 was Osaic Holdings, an estimated $189 sold.

Based on aggregated 13F filings for Q2 2025.